Craig A Johnson - Net Worth and Insider Trading

Craig A Johnson Net Worth

The estimated net worth of Craig A Johnson is at least $220,996 dollars as of 2024-11-13. Craig A Johnson is the Director of Mirati Therapeutics Inc and owns about 3,475 shares of Mirati Therapeutics Inc (MRTX) stock worth over $203,983. Craig A Johnson is the Director of Heron Therapeutics Inc and owns about 13,292 shares of Heron Therapeutics Inc (HRTX) stock worth over $17,014. Craig A Johnson is also the Director of Odonate Inc and owns about 0 shares of Odonate Inc (ODTC) stock worth over $0. Details can be seen in Craig A Johnson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig A Johnson has not made any transactions after 2021-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Craig A Johnson

To

Craig A Johnson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Craig A Johnson owns 8 companies in total, including Mirati Therapeutics Inc (MRTX) , La Jolla Pharmaceutical Co (LJPC) , and Heron Therapeutics Inc (HRTX) among others .

Click here to see the complete history of Craig A Johnson’s form 4 insider trades.

Insider Ownership Summary of Craig A Johnson

Ticker Comapny Transaction Date Type of Owner
MRTX Mirati Therapeutics Inc 2021-01-21 director
LJPC La Jolla Pharmaceutical Co 2022-08-22 director
HRTX Heron Therapeutics Inc 2021-12-21 director
LIMIT LIMIT 2020-12-29 director
LIMIT LIMIT 2011-02-10 director
LIMIT LIMIT 2011-08-01 Chief Financial Officer
LIMIT LIMIT 2010-06-16 Sr. VP & CFO and Secretary
LIMIT LIMIT 2009-02-03 V.P. Finance & CFO & Secretary

Craig A Johnson Latest Holdings Summary

Craig A Johnson currently owns a total of 3 stocks. Among these stocks, Craig A Johnson owns 3,475 shares of Mirati Therapeutics Inc (MRTX) as of January 21, 2021, with a value of $203,983 and a weighting of 92.3%. Craig A Johnson owns 13,292 shares of Heron Therapeutics Inc (HRTX) as of December 21, 2021, with a value of $17,014 and a weighting of 7.7%. Craig A Johnson also owns 0 shares of Odonate Inc (ODTC) as of December 29, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Craig A Johnson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRTX Mirati Therapeutics Inc 2021-01-21 3,475 58.70 203,983
HRTX Heron Therapeutics Inc 2021-12-21 13,292 1.28 17,014
ODTC Odonate Inc 2020-12-29 0 17,050.00 0

Holding Weightings of Craig A Johnson


Craig A Johnson Form 4 Trading Tracker

According to the SEC Form 4 filings, Craig A Johnson has made a total of 2 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 15,000 shares on January 21, 2021, which brought Craig A Johnson around $3 Million.

According to the SEC Form 4 filings, Craig A Johnson has made a total of 3 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Heron Therapeutics Inc is the sale of 250 shares on December 21, 2021, which brought Craig A Johnson around $2,433.

According to the SEC Form 4 filings, Craig A Johnson has made a total of 1 transactions in Odonate Inc (ODTC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Odonate Inc is the acquisition of 0 shares on December 29, 2020, which cost Craig A Johnson around $51,000.

Insider Trading History of Craig A Johnson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Craig A Johnson Trading Performance

GuruFocus tracks the stock performance after each of Craig A Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig A Johnson is -81.83%. GuruFocus also compares Craig A Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig A Johnson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Craig A Johnson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Craig A Johnson

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 33.74 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 34.08 LIMIT LIMIT LIMIT LIMIT LIMIT

Craig A Johnson Ownership Network

Ownership Network List of Craig A Johnson

No Data

Ownership Network Relation of Craig A Johnson

Insider Network Chart

Craig A Johnson Owned Company Details

What does Mirati Therapeutics Inc do?

Who are the key executives at Mirati Therapeutics Inc?

Craig A Johnson is the director of Mirati Therapeutics Inc. Other key executives at Mirati Therapeutics Inc include EVP & Chief Commercial Officer Benjamin Hickey , Sr. Vice President & Chief Scie Jamie Christensen , and Interim CFO Aaron Ondrey .

Mirati Therapeutics Inc (MRTX) Insider Trades Summary

Over the past 18 months, Craig A Johnson made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 8,522 shares made by Jamie Christensen , a net sale of 5,907 shares made by Benjamin Hickey , and a net purchase of 2,517,946 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,076 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,509,661 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mirati Therapeutics Inc Insider Transactions

No Available Data

Craig A Johnson Mailing Address

Above is the net worth, insider trading, and ownership report for Craig A Johnson. You might contact Craig A Johnson via mailing address: C/o Pure Bioscience, 1725 Gillespie Way, El Cajon Ca 92020.